About Us

Crionna represents the intelligent application of science to clinical trial management. Our goal is to assist our clients in the fast delivery of safe and effective therapies to patients with high unmet needs.

At Crionna we aim for long term relationships with our clients based on the quality of our work and our attention to detail. We take care when preparing timelines and study budgets to ensure that the information is realistic and affordable. Regardless of the size of any company the Project Team is dependent on individuals and at Crionna we guarantee a highly motivated, dynamic team who enjoy their work. As a company we place a lot of importance on providing our people with challenging and exciting projects to ensure high motivation and interest. Our flexible and informal approach allows us to compliment emerging Biotech and Device companies ensuring an enjoyable and synergistic working relationship.

Managing Director - Lynne Douglas

Lynne has over 20 years experience in the Pharmaceutical industry and a broad background spanning scientific and commercial research.

Following several years in research, both in the UK and Switzerland, Lynne moved into clinical R & D gaining trial design and management experience in companies such as Novartis, Pfizer and medical device specialists Sulzer Vascutek.

Moving into contract clinical research, Lynne became Clinical Development Manager of an Oncology focussed CRO, with responsibility for leading a team of experienced Project Managers, providing support and advice to new clients on study optimisation, Orphan Drug applications and Global Phase III trial management.

In 2004 Lynne was a founding member of Crionna, leading the company to successfully compete against Global CROs for US sponsored clinical trial contracts. The company quickly established a reputation for professional excellence and subsequently expanded their services to clinical development consultancy.

Lynne Douglas
Telephone: 08452340239
Email: info@crionna.co.uk